Renal scarring associated with vesico-ureteric reflux (VUR), most commonly detected in young children, is associated with a significant risk of developing hypertension in later life. Hypertension in reflux nephropathy contributes significantly to morbidity including deterioration of renal function. The mechanism of onset of hypertension is not clear although abnormalities of the renin-angiotensin system and sodium/potassium ATPase activity have been described in some cases. It is becoming clear that radiologically detectable renal scars or small kidneys may histologically indicate a variety of diagnoses. Prediction of the risk of developing hypertension in individual cases is difficult and there-
What is reflux nephropathy?
Reflux nephropathy is defined as focal renal scarring of one or both kidneys resulting from primary vesicoureteric reflux (VUR) and urinary tract infection (UTI). Primary VUR is common in young children (estimated incidence in the general population 0.1-1%, 1, 2 in children presenting with UTI 12-50% 1, 3 ), but disappears with time in the majority (80%). 4, 5 A substantial number of subjects with VUR have established renal scars at diagnosis [6] [7] [8] with an increasing incidence with age (10% in preterm infants with VUR, 9 26% in children less than 8 years, 6 47% in children older than 8 years 6 and 94% in adults 5 ) or develop new scars at follow-up (5-58%). 7, 8, 10, 11 There is a correlation between the extent of scarring and grade of VUR 12, 13 although there is some disagreement on this issue.
14 It is also clear that renal scars may be seen in the absence of demonstrable VUR. 15 It is considered that renal scarring mainly occurs in younger subjects (Ͻ5 years). 6, 16 and that it is more likely to occur in the presence of urological abnormalities, 7 with recurrent UTI 10 particularly with upper tract involvement (eg, pyelonephritis), 7 and certain bacterial pathogens.
fore regular follow-up remains the only current means of recognising these subjects. Although prevention of renal scar development in children with VUR may offer some benefit in reducing the incidence of hypertension, there is no uniform action that can definitely achieve this, particularly in the very young, before any urinary infection occurs. Primary VUR seems to be a disorder with mendelian dominant inheritance and location of the gene may offer some hope of early identification within certain families. Timely introduction of preventative measures may then be possible even though reservations exist about their effectiveness.
The problem
From a number of studies there is evidence that renal scars increase the risk of developing hypertension and progressive renal failure during later life. 1, [18] [19] [20] Hypertension affects at least 10% of children with renal scars, [21] [22] [23] and is the commonest cause of severe hypertension in childhood. [24] [25] [26] [27] In adults with reflux nephropathy the prevalence of hypertension is much higher (38-50%) 5, 28, 29 reflecting the continued risk of developing hypertension at any age. Jacobson et al (1989) found that hypertension in some adults with renal scarring did not occur until 27 years of follow-up. 30 Malignant hypertension due to reflux nephropathy is uncommon but has been reported in younger children and adolescents 20, 31 and in women taking oral contraceptives. 32 The incidence of hypertension is higher in pregnancy in subjects with reflux nephropathy 33 when first manifestations of clinically latent reflux nephropathy may be seen. 29, 34 If hypertension is present at conception, the risk of fetal death increases by four to five-fold. 35 Although reflux nephropathy was first defined as pyelonephritic scarring associated with UTI and VUR the current terminology includes several forms of renal damage associated with VUR and resulting in cortical scarring, clubbed calyces and generalised parenchymal loss (as in obstructive uropathy). Additionally, renal dysplasia, renal hypoplasia, the Ask-Upmark kidney, 36, 37 and even small kidneys due to renal growth retardation 38, 39 are known either to co-exist with or be misdiagnosed as reflux nephropathy in many cases due to non-availability of an investigation that will reliably distinguish between the above pathologies. Risdon and colleagues found histopathological evidence for renal dysplasia in a subgroup of children (only in males) who had had unilateral nephrectomies for reflux nephropathy. 40 With the recent introduction of prenatal ultrasound a group of patients has been discovered who have dilatation of the urinary tract antenatally and on postnatal cystography primary VUR is identified. 41 These neonates are mainly boys with two-thirds having bilateral reflux and between a third and a half demonstrating reduced renal function on isotope renography, even in the absence of a preceding UTI. 42 Crabbe showed that four of 24 kidneys (in 15 children with primary VUR who were non-infected) were globally abnormal (ie, small kidneys without focal scarring) suggesting that some of these children may have had abnormal renal parenchyma from birth. 43 Therefore renal hypoplasia and dysplasia may mimic scarring, co-exist with VUR with or without UTI and are known to be associated with hypertension. 18, 44 The Ask-Upmark kidney, as originally described 36 was an abnormal kidney with an external circumferential groove marking the site of an elongated calyx with a very thin band of parenchyma (a segment lacking a medullary pyramid in relation to the dilated calyx, ie, renal segmental hypoplasia) associated with VUR and often also categorised as reflux nephropathy. It appears to be in over 50% of cases complicated by hypertension 45, 46 and seems to be associated in terms of hypertension with complete cure more frequently by nephrectomy than is seen in other patients with reflux nephropathy. 46 Although Ask-Upmark himself considered these kidney lesions were congenital in origin some investigators disagree, 45, 47 Neither the prevalence of this condition among subjects with reflux nephropathy nor the true incidence of hypertension among this subgroup is known. This mixture of pathology that often co-exists or overlaps with pyelonephritic scarring suggests that a number of studies that were undertaken in the past, many of which were dependent on the diagnosis of reflux nephropathy made postnatally by intravenous urography, may have included a proportion of cases with abnormal parenchyma from birth. This may have contributed to the vast differences in the reported incidences of reflux nephropathy and its associated complications. The data may have been further contaminated by reno-vascular hypertension in children and adolescents that can also be associated with reflux nephropathy 24, 48 and by the finding of reflux nephropathy in some adults previously thought to have primary hypertension. 49 In addition, methodological flaws in various studies as highlighted by Shanon and Feldman 50 may have contributed to differences in the reported incidence of hypertension in reflux nephropathy.
Non-scarred kidneys in association with VUR but with a reduced contribution to renal function (Ͻ43%) on DMSA isotope scanning have been described, which may have a pathogenesis similar to that of the previously referred to small abnormal kidneys; a vascular, renal dysplastic or obstructive aetiology. 51 Histologically these kidneys show segmental tubular atrophy with glomerular metamorphosis but no significant inflammation 52 suggesting mechanisms other than infection are involved in the pathogenesis. Whatever their aetiology, these kidneys also have the potential to cause hypertension. Conversely, histological appearances highly suggestive of reflux nephropathy can occur in radiologically normal kidneys.
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Risk factors for the development of hypertension
Age
The risk of developing hypertension in reflux nephropathy appears to be highest during adolescence and adulthood. 22, 30, 53, 54 Some studies undertaken in younger children report an absence of hypertension. 55 Severe hypertension due to reflux nephropathy, however, may occur at any age, especially in pre-adolescent children.
The hypertension risk in adults is difficult to assess due to confounding factors such as intake of oral contraceptives, increasing risk of essential hypertension and cumulative nature of reported data. The estimated prevalence of hypertension, however, in adults with renal scarring is 10-50%, 5,14,56,57 much higher than it is in children and is commonly associated with proteinuria and renal insufficiency.
Sex
Reflux nephropathy is commoner in females (M:F ratio of 1:5), 56, 57 but males more often appear to have bilateral scarring, persistent reflux 54 and complications such as proteinuria, hypertension or renal failure.
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Genetics
There is now convincing evidence obtained by segregation analysis suggesting familial occurrence of primary VUR is possibly inherited via a single dominant gene acting together with random environmental effects. 58, 59 The gene frequency is estimated to be 1:600, and new mutations seem unlikely as predicted by the above segregation analysis computer model. 59 Forty-five percent of gene carriers are predicted to have VUR or reflux nephropathy as adults and 15% are predicted to go on to develop renal failure compared to 0.05% and 0.001%, respectively, for those not carrying the gene. 59 However, there are no genetic clues yet for the recognition of subjects at risk of hypertension due to renal scarring 60 although ACE gene D allele homozygosity appear to increase the risk of scar formation in children with VUR. 61 
Degree of reflux and the degree of scarring
Hypertension is more likely in patients with severe bilateral reflux 28 and in the presence of bilateral scarring, 28, 29, 62 but can occur in the presence of unilateral scarring 20, 62 and irrespective of the degree of scarring. 63 Hypertension, when present, accelerates the progression of renal failure in reflux nephropathy, 1, 19, 22, [64] [65] [66] making early diagnosis and treatment important. [67] [68] [69] The mechanisms involved in the development of renal scars, that may also be relevant in the development of hypertension, however, are not well understood. Microvascular injury with loss of vessels, 70 bacterial infection, 71 immune responses to irritant urinary substances (Tamm-Horsfall protein) forced into the interstitium during intrarenal reflux have been blamed. 72 Focal glomerular sclerosis, a lesion found in patients with proteinuria and reflux nephropathy, has been identified not only in scarred kidneys, but also may be seen in contralateral, unscarred kidneys without VUR, suggesting a role for a humoral factor or perhaps a hyperfiltration phenomenon. 49 A histological review of 86 paediatric nephrectomy specimens from patients with VUR showed focal segmental glomerulosclerosis (FSGS) in 18 patients but no association with age, gender, renal hypoplasia or postnatal cortical loss. 73 Within the index population FSGS was significantly associated with hypertension. 73 The cortical scarring with destruction of nephrons may be a factor subjecting the remaining nephrons to compensatory hypertrophy and hyperfiltration causing FSGS as in renal agenesis 74 or unilateral nephrectomy. 75 Other mechanisms such as altered prostaglandin synthesis 76 and glomerular hypertension 77 may have a role in precipitating the onset of FSGS in these cases. 73 The association between FSGS and hypertension in these cases, however, is unexplained.
Mechanisms of hypertension
Plasma renin activity (PRA)
The renin-angiotensin system has been implicated in the genesis of hypertension in reflux nephropathy, with a raised peripheral plasma renin activity (PRA) being a frequent finding. 78, 79 PRA either increases to abnormal levels 80, 81 or fails to decrease normally with chronological age 82 in children with renal scarring but offers no predictive value in identification of subjects who may develop hypertension in later life. 20 Furthermore there is no direct correlation between PRA and blood pressure in reflux nephropathy, although clearly in some cases high blood pressure and high renin levels normalise with removal of the affected kidney.
A rise and subsequently a levelling out of systolic blood pressure standard deviation scores together with a rise in PRA standard deviation scores with age during childhood and teenage years but with a reduction in adulthood is seen in reflux nephropathy. 20 These findings suggest a dissociation between blood pressure and renin in reflux nephropathy with age. 83 Other factors such as hormonal contraceptives that reduce PRA, 84 but can cause hypertension 85 may confound these observations. Some argue that PRA may not be reflective of the renin activity at the tissue level 86 and therefore observations of PRA in reflux nephropathy can only be a very crude guide to the actions of renin-angiotensin system in this condition.
Current theory holds that renal scarring is central to the pathogenesis of hypertension in patients with UTI and VUR. 22, 44, 79, 80, 87 Arterial damage in scarred areas could lead to segmental ischaemia and thus renin driven hypertension. [88] [89] [90] It has been noted, however, that not all patients with high renin levels are hypertensive 79 and in some patients plasma renin levels revert to normal spontaneously. 80 It might be speculated that such a reversion to normal could follow the complete loss of the blood supply to previously scarred ischaemic areas of kidney causing necrosis and cessation of renin release.
Sodium transport
Abnormal sodium transport is a feature of human hypertension, in particular the sodium-potassium ATPase (Na/K ATPase) dependent pump and sodium-lithium countertransport (LCT). [91] [92] [93] Digitalis-like sodium transport inhibitors may be involved in the aetiology of the former, [94] [95] [96] especially in the presence of renal impairment. 97 It has recently been demonstrated that there is a reduction in Na/K ATPase pump sites (Bmax) in a group of children and adolescents with reflux nephropathy and a proposal has been made that a circulating ouabain-like inhibitor may be to blame contributing to the onset of hypertension. 98 Lithium countertransport, the best characterised intermediate phenotype in human hypertension, 99 however, appears to be uninfluenced in reflux nephropathy suggesting that essential hypertension and family history of hypertension are unlikely contributors to hypertension in these cases.
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Renal artery stenosis
The finding of contralateral renal artery stenosis due to fibro-muscular dysplasia in some patients in whom unilateral reflux nephropathy was thought to be responsible for the hypertension has caused further confusion. 100 The interpretation of such observations is that the observed renal scarring is due to intra-renal renovascular pathology resulting in parenchymal damage. The problem may be more common than has been reported since very few children with what is considered to be reflux nephropathy undergo angiographic investigation to exclude renovascular disease as a cause of the 'scarred' kidney or kidneys. Scarring without the characteristic calyceal abnormalities of reflux nephropathy in children in whom there is no history of UTI or VUR are those in whom such underlying pathology might exist. It has also been considered that the so called 'Ask-Upmark' kidney 36 which mimics reflux nephropathy has a possibly intrauterine renovascular aetiology.
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Other vasoactive substances
It has been noted that some patients with reflux nephropathy with raised plasma renin may remain normotensive. 20 This kind of phenomena has not been clearly explained and natural anti-hypertensive vasoactive peptides may be involved, for example natriuretic hormones, 102, 103 prostaglandins, 104 renomedullary lipids, 105 adrenomedullin 106 and nitric oxide. 107 The role of such compensatory hypotensive systems or lack of them in the onset of hypertension in reflux nephropathy is yet to be clearly defined. The role of endothelin in reflux nephropathy, the most powerful vasoconstrictor yet known, is also unclear at present.
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Management
Most subjects with reflux nephropathy associated hypertension are managed conservatively and may continue to be so even after surgical intervention. Angiotensin-converting enzyme (ACE) inhibitors are useful therapeutic agents in this condition not only because they are effective anti-hypertensives but also because of their positive effects on cardiac function, peripheral vasculature, proteinuria and renal sparing properties. 28, 109, 110 Adequate control of hypertension is considered one of the most important measures that would help curtail progression of these cases to end-stage renal failure. [111] [112] [113] Hypertension in this population, however, is currently recognised by comparison of blood pressure measurements against the general standards intended for normal population. 114 It is very likely, therefore, that a proportion of cases who have had a 'relative' rise in blood pressure, not reaching a defined level of abnormality yet having a detrimental effect on the progression of their renal disease could be missed. These subjects would, hence, not qualify for anti-hypertensive therapy (for example ACE inhibitors) until a later stage in their condition, when much renal damage might have occurred. This aspect has not been previously studied, and may not be feasible until the blood pressures of these children are recorded on centile charts as are currently utilised for body weight or height. At least for the time being, therefore, it may be appropriate to consider anti-hypertensive therapy at least in children in whom there is evidence of target organ damage such as proteinuria and a 'relative' rise in blood pressure in comparison to their previous measurements.
It is known that the hypertension of reflux nephropathy can be benefited by nephrectomy. 115 Removal of a scarred kidney when the contralateral kidney is thought to be normal does not, however, always cure hypertension. 63 Moreover, differential renal vein renin activity measurements in hypertensive patients with unilateral scarring may not localise the increased renin release to the scarred kidney and attention must therefore be paid to the PRA in the renal vein of the radiologically normal kidney. While the ratio of renal vein renin in the scarred versus the normal kidney may be greater than 1.5 (a figure that implies localised release from the affected kidney), renal injury to the apparently normal kidney should be suspected when the ratio of renal vein renin from the normal kidney to that in the inferior vena cava below the renal veins is increased as well. 116 This is because a pathological renin drive from the apparently normal kidney is not suppressed (as in a true normal kidney) by increased blood pressure and increased renin release from the contralateral diseased kidney.
There is, however, controversy regarding the validity of renal vein renin ratios in unilateral reflux nephropathy. In a study of 17 normotensive and 12 hypertensive patients with strictly unilateral nephropathy, there were only three normotensive and two hypertensive patients with a renal vein renin ratio exceeding 1.5, indicating that the reninangiotensin system may not consistently have a role in the hypertension of unilateral reflux nephropathy. 117 On the other hand it could be argued that in the normotensive unilateral scarred kidney patients with a renal vein renin ratio of more than 1.5 the non-scarred kidney must be normal as opposed to 'apparently' normal and responds to the effects of increased blood pressure by natriuresis ultimately producing normotension.
Most clinicians agree that there is little benefit obtained by surgical correction of VUR if the subject has developed hypertension, proteinuria or renal insufficiency. However, there is still much disagreement concerning the indications for anti-reflux surgery earlier on in the disease process. There is evidence that anti-reflux surgery has helped significantly to reduce the number of urinary tract infections but not the incidence of hypertension or other complications. 14, 22 There is no difference if a comparison is made between medical and surgical management in terms of new scar development or the progression of renal scars. 118 The Birmingham Reflux Study Group compared operative versus nonoperative management of children with gross reflux over 5 years and concluded that neither treatment can claim superiority in terms of reducing the incidence of breakthrough UTI, renal excretory function, concentrating ability, renal growth, progression of existing scars, or new scar formation. 119, 120 Some suggest that if surgery is to be beneficial it must be undertaken very early in life, as renal damage associated with reflux invariably develops in early childhood. Adequate antibiotic prophylaxis, however, could also be equally effective. The complications of early surgery, however, especially the later development of mega-ureters obviously counter balance any benefits. Furthermore, the group of patients, particularly males, who have VUR without UTI but associated with renal dysplasia, may not benefit at all from anti-reflux surgery.
There is no evidence, however, to suggest that prophylactic nephrectomy is of value in reducing the risk of developing hypertension 121 in reflux nephropathy, whatever the cause.
Prevention of reflux nephropathy
Prevention of renal scarring appears to be the only available method of preventing reflux nephropathy associated hypertension, as there are no concrete predisposing factors or reliable predictive factors that will identify cases at risk. Factors that are of importance in the development of pyelonephritic scarring include youth, 7, 122 reflux, 123 the character of UTI and the number of pyelonephritic episodes. 124 Prevention of the development of renal scars in VUR will, therefore, depend on early identification of patients at risk, ie, infants and children after the first UTI, siblings and offspring of affected individuals, as well as the aggressive treatment of UTI, 87, 125 minimisation of intra-vesical pressure as well as education of parents, physicians and patients.
There are no major studies at present that are directed at improving the ability to prevent this disease. There is a wide diversity of opinion concerning the approach to be taken. For instance, there is no clear protocol for the identification and management of siblings or offspring of affected subjects, that might play a role in preventing reflux nephropathy especially in infancy. Such a programme might be of paramount importance and lead to a reduction of late complications such as hypertension and renal failure that would far outweigh the costs of implementation. On the other hand there is strong criticism of this timed invasive approach, including resistance toward the extensive investigation of girls at their first UTI (excluding infants), in view of it not being considered to be cost-effective. 126 Antenatal scanning may identify some subjects who may go on to develop renal scars and although not that sensitive offers some hope for early detection.
Prevention of VUR, on the other hand is more complicated. The familial aggregation of some cases has led to the belief, already referred to, that primary VUR is probably associated with a single dominant gene. Although initial investigations by linkage analysis have been made, there are no clues to the location of the gene yet. 127 However, identification of the VUR gene, although helping to prevent some morbidity of this condition (by intensified focus on prophylactic measures) and unnecessary investigation of patients without it, is unlikely to be that influential in making a major impact on renal scarring.
Conclusions
It is now clear that reflux nephropathy may include a mixture of disorders; renal scarring as a consequence of pyelonephritis, renal hypoplasia, renal dysplasia or even misdiagnosed renovascular disease. Furthermore several pathologies may co-exist. The studies to date on reflux nephropathy do not distinguish these diagnoses clearly and therefore reported incidences of complications vary widely. This matter is difficult to resolve, even by renal biopsy, as a mixture of pathologies may occur together and there is no guarantee that a biopsy will necessarily reveal the true diagnosis. Therefore, it is probably more appropriate that reflux nephropathy is considered as a 'syndrome' until the underlying 'disease' is clarified or to be redefined altogether. Unfortunately Hodson's remark 128 in 1978 that reflux nephropathy 'a common preventable disease of the kidney in the young, bedevilled by a lack of information regarding many of its important aspects, and the absence of any co-ordinated action to obtain it' still appears to hold true 20 years on.
Recommendations
It is clear that reflux nephropathy needs lifelong follow-up as associated complications including hypertension can ensue at any age. What is not clear is whether children with VUR but no demonstrable scars radiologically are free of the risk of hypertension since radiological normality does not necessarily mean normal kidneys.
Hypertension when present, should be thoroughly investigated to exclude other pathologies such as renovascular disease especially in the presence of unilateral scarring. Renal vein renin studies may be helpful in some cases when deciding upon surgical treatment, but do not necessarily guarantee that the therapy will be curative. There are no definite features in reflux nephropathy that will identify subjects at increased risk of developing hypertension and therefore, unfortunately, regular follow-up remains the only means of recognising subjects who may require treatment.
The levels of blood pressure that enhances progression of renal damage in reflux nephropathy are currently obscure. The existing definitions are empirical and further studies are necessary to obtain new definitions, perhaps based on relative rises in blood pressure, so that early interventions can be initiated.
